ReviewCNS drugs2010
The pharmacoeconomics of cognitive enhancers in moderate to severe Alzheimer's disease.
Jaclyn Cappell et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
16 papers cite it
this paperpooled itcites it
ReviewCNS drugs2010
Jaclyn Cappell et al.PubMed ↗Publisher ↗
No numbers read from the abstract.